Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

ILOTYCIN GLUCEPTATE

ERYTHROMYCIN GLUCEPTATE

Standard Dose
EQ 250MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA).
  • Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.